These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35751132)

  • 1. Novel insights into the structural changes induced by disease-associated mutations in TDP-43: a computational approach.
    Sharma A; Dey P
    J Biomol Struct Dyn; 2023; 41(12):5624-5634. PubMed ID: 35751132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALS-causing D169G mutation disrupts the ATP-binding capacity of TDP-43 RRM1 domain.
    Dang M; Song J
    Biochem Biophys Res Commun; 2020 Apr; 524(2):459-464. PubMed ID: 32007267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of thermal unfolding simulations of RNA recognition motifs (RRMs) of TAR DNA-binding protein 43 (TDP-43).
    Prakash A; Kumar V; Meena NK; Hassan MI; Lynn AM
    J Biomol Struct Dyn; 2019 Jan; 37(1):178-194. PubMed ID: 29279008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of disease-related TDP-43 D169G mutation: linking enhanced stability and caspase cleavage efficiency to protein accumulation.
    Chiang CH; Grauffel C; Wu LS; Kuo PH; Doudeva LG; Lim C; Shen CK; Yuan HS
    Sci Rep; 2016 Feb; 6():21581. PubMed ID: 26883171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43).
    Shodai A; Morimura T; Ido A; Uchida T; Ayaki T; Takahashi R; Kitazawa S; Suzuki S; Shirouzu M; Kigawa T; Muto Y; Yokoyama S; Takahashi R; Kitahara R; Ito H; Fujiwara N; Urushitani M
    J Biol Chem; 2013 May; 288(21):14886-905. PubMed ID: 23558684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural heterogeneity in RNA recognition motif 2 (RRM2) of TAR DNA-binding protein 43 (TDP-43): clue to amyotrophic lateral sclerosis.
    Prakash A; Kumar V; Banerjee A; Lynn AM; Prasad R
    J Biomol Struct Dyn; 2021 Jan; 39(1):357-367. PubMed ID: 31914861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation.
    French RL; Grese ZR; Aligireddy H; Dhavale DD; Reeb AN; Kedia N; Kotzbauer PT; Bieschke J; Ayala YM
    J Biol Chem; 2019 Apr; 294(17):6696-6709. PubMed ID: 30824544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Computational Approach to Investigate TDP-43 RNA-Recognition Motif 2 C-Terminal Fragments Aggregation in Amyotrophic Lateral Sclerosis.
    Grassmann G; Miotto M; Di Rienzo L; Salaris F; Silvestri B; Zacco E; Rosa A; Tartaglia GG; Ruocco G; Milanetti E
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD.
    Afroz T; Chevalier E; Audrain M; Dumayne C; Ziehm T; Moser R; Egesipe AL; Mottier L; Ratnam M; Neumann M; Havas D; Ollier R; Piorkowska K; Chauhan M; Silva AB; Thapa S; Stöhr J; Bavdek A; Eligert V; Adolfsson O; Nelson PT; Porta S; Lee VM; Pfeifer A; Kosco-Vilbois M; Seredenina T
    Neurobiol Dis; 2023 Apr; 179():106050. PubMed ID: 36809847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proteinopathy of D169G and K263E mutants at the RNA Recognition Motif (RRM) domain of tar DNA-binding protein (tdp43) causing neurological disorders: A computational study.
    Bhandare VV; Ramaswamy A
    J Biomol Struct Dyn; 2018 Mar; 36(4):1075-1093. PubMed ID: 28330421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the aggregation-prone regions from structural domains of human TDP-43.
    Kumar V; Wahiduzzaman ; Prakash A; Tomar AK; Srivastava A; Kundu B; Lynn AM; Imtaiyaz Hassan M
    Biochim Biophys Acta Proteins Proteom; 2019 Mar; 1867(3):286-296. PubMed ID: 30315897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folding of the RNA recognition motif (RRM) domains of the amyotrophic lateral sclerosis (ALS)-linked protein TDP-43 reveals an intermediate state.
    Mackness BC; Tran MT; McClain SP; Matthews CR; Zitzewitz JA
    J Biol Chem; 2014 Mar; 289(12):8264-76. PubMed ID: 24497641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.
    Rutherford NJ; Zhang YJ; Baker M; Gass JM; Finch NA; Xu YF; Stewart H; Kelley BJ; Kuntz K; Crook RJ; Sreedharan J; Vance C; Sorenson E; Lippa C; Bigio EH; Geschwind DH; Knopman DS; Mitsumoto H; Petersen RC; Cashman NR; Hutton M; Shaw CE; Boylan KB; Boeve B; Graff-Radford NR; Wszolek ZK; Caselli RJ; Dickson DW; Mackenzie IR; Petrucelli L; Rademakers R
    PLoS Genet; 2008 Sep; 4(9):e1000193. PubMed ID: 18802454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the aggregation mechanism of RNA recognition motif domains in TDP-43: a theoretical exploration.
    Liu W; Li C; Shan J; Wang Y; Chen G
    R Soc Open Sci; 2021 Aug; 8(8):210160. PubMed ID: 34457335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy.
    Chen HJ; Topp SD; Hui HS; Zacco E; Katarya M; McLoughlin C; King A; Smith BN; Troakes C; Pastore A; Shaw CE
    Brain; 2019 Dec; 142(12):3753-3770. PubMed ID: 31605140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The crystal structure of TDP-43 RRM1-DNA complex reveals the specific recognition for UG- and TG-rich nucleic acids.
    Kuo PH; Chiang CH; Wang YT; Doudeva LG; Yuan HS
    Nucleic Acids Res; 2014 Apr; 42(7):4712-22. PubMed ID: 24464995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Baloh RH
    FEBS J; 2011 Oct; 278(19):3539-49. PubMed ID: 21777387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
    Root J; Merino P; Nuckols A; Johnson M; Kukar T
    Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease.
    Pottier C; Bieniek KF; Finch N; van de Vorst M; Baker M; Perkersen R; Brown P; Ravenscroft T; van Blitterswijk M; Nicholson AM; DeTure M; Knopman DS; Josephs KA; Parisi JE; Petersen RC; Boylan KB; Boeve BF; Graff-Radford NR; Veltman JA; Gilissen C; Murray ME; Dickson DW; Rademakers R
    Acta Neuropathol; 2015 Jul; 130(1):77-92. PubMed ID: 25943890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics.
    Mackenzie IR; Nicholson AM; Sarkar M; Messing J; Purice MD; Pottier C; Annu K; Baker M; Perkerson RB; Kurti A; Matchett BJ; Mittag T; Temirov J; Hsiung GR; Krieger C; Murray ME; Kato M; Fryer JD; Petrucelli L; Zinman L; Weintraub S; Mesulam M; Keith J; Zivkovic SA; Hirsch-Reinshagen V; Roos RP; Züchner S; Graff-Radford NR; Petersen RC; Caselli RJ; Wszolek ZK; Finger E; Lippa C; Lacomis D; Stewart H; Dickson DW; Kim HJ; Rogaeva E; Bigio E; Boylan KB; Taylor JP; Rademakers R
    Neuron; 2017 Aug; 95(4):808-816.e9. PubMed ID: 28817800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.